Mackay Shields LLC Harvard Bioscience Inc Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.93 - $4.59 $80,172 - $190,668	-41,540 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$2.77 - $4.38 $8,587 - $13,578	3,100 Added 8.06%	41,540 $179,000
Q4 2018 Feb 14, 2019	BUY	$3.03 - $5.0 $42,541 - $70,200	14,040 Added 57.54%	38,440 $123,000
Q3 2018 Nov 14, 2018	SELL	$5.0 - $6.65 $27,000 - $35,910	-5,400 Reduced 18.12%	24,400 $128,000
Q2 2018 Aug 06, 2018	BUY	$4.2 - $5.95 $125,160 - $177,310	29,800 New	29,800 $160,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.